When correlation between serum AIFM3 levels and the clinicopathological parameters of CCA patients were examined, serum AIFM3 levels correlated significantly with lymph node metastasis, age, and the patients’ overall survival (OS). This evidence concerns the gene AIFM3 and metastatic malignant neoplasm in the lymph nodes.